T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Hovnanian Enterprises
HOV
$799M
| $569K | ﹤0.01% |
5,513
-800
| -13% | -$78.3K |
|
1902
WisdomTree
WT
$3.44B
| $567K | ﹤0.01% |
36,200
| – | – |
|
|
FMBI
1903
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $566K | ﹤0.01% |
33,093
| – | – |
|
1904
United Fire Group
UFCS
$1.38B
| $565K | ﹤0.01% |
19,000
+3,100
| +19% | +$91.1K |
|
|
FOE
1905
DELISTED
Ferro Corporation
FOE
| $565K | ﹤0.01% |
43,560
-5,400
| -11% | -$70.9K |
|
1906
American States Water
AWR
$3.52B
| $564K | ﹤0.01% |
14,969
-2,332
| -13% | -$80.2K |
|
|
SKX
1907
DELISTED
Skechers
SKX
| $564K | ﹤0.01% |
30,600
-5,400
| -15% | -$101K |
|
1908
International Bancshares
IBOC
$4.57B
| $563K | ﹤0.01% |
21,214
| – | – |
|
1909
Neogen
NEOG
$2.59B
| $563K | ﹤0.01% |
30,267
-4,266
| -12% | -$70.2K |
|
1910
Element Solutions
ESI
$9.51B
| $560K | ﹤0.01% |
24,100
-2,812,135
| -99% | -$69.5M |
|
|
ENZY
1911
DELISTED
Enzymotec Ltd
ENZY
| $556K | ﹤0.01% |
372,890
-53,984
| -13% | -$392K |
|
1912
Interactive Brokers
IBKR
$41.4B
| $554K | ﹤0.01% |
76,000
-31,600
| -29% | -$211K |
|
1913
Fulton Financial
FULT
$4.69B
| $553K | ﹤0.01% |
44,776
-7,800
| -15% | -$91.9K |
|
|
SENEB
1914
Seneca Foods Class B
SENEB
$1.33B
| $553K | ﹤0.01% |
17,170
| – | – |
|
|
OVTI
1915
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
| $553K | ﹤0.01% |
21,261
+675
| +3% | +$17.9K |
|
|
UPL
1916
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $547K | ﹤0.01% |
41,560
+1,700
| +4% | +$34.3K |
|
|
EXCU
1917
DELISTED
Exelon Corporation
EXCU
| $546K | ﹤0.01% |
10,160
+1,860
| +22% | +$97.7K |
|
1918
Park National Corp
PRK
$3.75B
| $545K | ﹤0.01% |
6,155
| – | – |
|
1919
EnerSys
ENS
$7.2B
| $543K | ﹤0.01% |
8,800
-2,400
| -21% | -$142K |
|
|
TRLA
1920
DELISTED
TRULIA INC (DEL)
TRLA
| $543K | ﹤0.01% |
11,800
| – | – |
|
|
INFN
1921
DELISTED
Infinera Corporation Common Stock
INFN
| $542K | ﹤0.01% |
36,800
-4,900
| -12% | -$64.9K |
|
|
DWRE
1922
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
| $541K | ﹤0.01% |
9,400
+1,600
| +21% | +$90K |
|
1923
Advanced Micro Devices
AMD
$789B
| $540K | ﹤0.01% |
202,265
-151,880
| -43% | -$417K |
|
|
CAB
1924
DELISTED
Cabela's Inc
CAB
| $540K | ﹤0.01% |
10,241
-1,400
| -12% | -$73.6K |
|
|
PVTB
1925
DELISTED
PrivateBancorp Inc
PVTB
| $540K | ﹤0.01% |
16,160
| – | – |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.